Skip to main content
2026 ASCRS Annual Scientific Meeting Main banner
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
CME
CME
Invitation/Ticketed Event
Invitation/Ticketed Event
Invited Lectureship
Invited Lectureship
Award Recipient
Award Recipient
Live Streamed Session
Live Streamed Session
Nurses Contact Hours
Nurses Contact Hours
Self-Assessment
Self-Assessment
Live Q&A and Polling
Live Q&A and Polling
Social
Social
Industry
Industry

Session:: New Frontiers in Cancer: From The Tumor Microenvironment to CARs

Novel Immunotherapy Treatment for Colorectal Cncer

Tuesday, May 12, 2026
12:20 PM - 12:30 PM ET

    Faculty(s)

  • Michael Overman, MD (he/him/his)

    Professor
    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center
    Houston, Texas, United States

    All disclosed relationships have been reviewed and managed prior to the start of this activity. Any relevant relationships will be listed below. Genentech/Roche: Clinical Trial Investigator (Ongoing); GSK: Consultant (Terminated, January 31, 2025); nouscom: Clinical Trial Investigator (Ongoing); Regeneron: Clinical Trial Investigator (Ongoing)

The role of immunotherapy for MSI-H colorectal cancers will be discussed with a primary focus upon the role of this therapy for localized MSI-H rectal and colon cancers. A deep dive into the nonoperative management of MSI-H colon cancer will be presented.